Literature DB >> 872096

Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.

F P Mettler, D M Young, J M Ward.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 872096

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  23 in total

1.  Lipid lowering: an important factor in preventing adriamycin-induced heart failure.

Authors:  N Iliskovic; P K Singal
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  Rescue by coenzyme Q10 from electrocardiographic abnormalities caused by the toxicity of adriamycin in the rat.

Authors:  K Folkers; J Y Choe; A B Combs
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  The influence of lipoic acid on adriamycin-induced hyperlipidemic nephrotoxicity in rats.

Authors:  Kumaravel Palanichamy Malarkodi; Andithangal Venkatesan Balachandar; Palaninathan Varlakshmi
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

4.  Elevation of serum lipid peroxide level associated with doxorubicin toxicity and its amelioration by [dl]-alpha-tocopheryl acetate or coenzyme Q10 in mouse (doxorubicin, toxicity, lipid peroxide, tocopherol, coenzyme Q10).

Authors:  N Yamanaka; T Kato; K Nishida; T Fujikawa; M Fukushima; K Ota
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 5.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

6.  Reduction of chronic doxorubicin cardiotoxicity in beagle dogs by bis-morpholinomethyl derivative of razoxane (ICRF-159).

Authors:  E H Herman; V J Ferrans; H B Bhat; D T Witiak
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  Chronic effects of a novel synthetic anthracycline derivative (SM-5887) on normal heart and doxorubicin-induced cardiomyopathy in beagle dogs.

Authors:  T Noda; T Watanabe; A Kohda; S Hosokawa; T Suzuki
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

8.  Lysosomal alterations in heart and liver of mice treated with doxorubicin.

Authors:  N Gebbia; G Leto; M Gagliano; F M Tumminello; L Rausa
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

9.  Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants.

Authors:  J F Van Vleet; V J Ferrans; W E Weirich
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

10.  Effects of chronic administration of doxorubicin on plasma levels of prostaglandins, thromboxane B2, and fatty acids in rats.

Authors:  T W Robison; S N Giri
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.